From Yahoo/Reuters:
“U.S. mulls paying companies, tax
breaks to pull supply chains from China”
U.S. lawmakers and officials are
crafting proposals to push American companies to move operations or key
suppliers out of China that include tax breaks, new rules, and carefully
structured subsidies. Interviews with a dozen current and former government
officials, industry executives and members of Congress show widespread
discussions underway - including the idea of a "reshoring fund"
originally stocked with $25 billion - to encourage U.S. companies to
drastically revamp their relationship with China. President Donald Trump has
long pledged to bring manufacturing back from overseas, but the recent spread
of the coronavirus and related concerns about U.S. medical and food supply chains
dependency on China are "turbocharging" new enthusiasm for the idea
in the White House. On Thursday, Trump signed an executive order that gave a
U.S. overseas investment agency new powers to help manufacturers in the United
States. The goal, Trump said, is to "produce everything America needs for
ourselves and then export to the world, and that includes medicines." But
the Trump administration itself remains divided over how best to proceed, and
the issue is unlikely to be addressed in the next fiscal stimulus to offset the
coronavirus downturn. Congress has begun work on another fiscal stimulus
package but it remains unclear when it might pass. The push takes on special
resonance in an election year. While anti-China, pro-American job proposals
could play well with voters, giving taxpayer money or tax breaks to companies
that moved supply chains to China at a time when small business is flailing may
not.
BIPARTISAN APPEAL: Both Republicans and Democrats are crafting
bills to decrease U.S. reliance on China-made products, which accounted for
some 18% of overall imports in 2019. "The whole subject of supply chains
and integrity of supply chains... does have a greater place in members'
minds," Representative Mac Thornberry, the top Republican on the House of
Representatives Armed Services Committee, told reporters May 7. The medical
supply chain and defense-related goods are top of the list. "Coronavirus
has been a painful wakeup call that we are too reliant on nations like China
for critical medical supplies," said U.S. Senator Lindsey Graham in a
press release on Friday. He is expected to issue a new bill this week. Republican
Senator Josh Hawley is pushing for local content rules for medical supply
chains, and "generous investment subsidies" to encourage increased
domestic production of a range of goods and components. Republican Senator
Marco Rubio introduced a bill May 10 that would bar sale of some sensitive
goods to China, and raise taxes on U.S. companies' income from China. A
bipartisan bill introduced by Democratic Representative Anna Eschoo and
Republican Representative Susan Brooks would commission a panel to recommend
ways to cut drug supply reliance on China. Republican Representative Mark
Green's "SOS Act" proposes funding takeovers of vulnerable U.S.
companies that are critical to our national security. Lawmakers also hope to
include reshoring provisions in the National Defense Authorization Act, or
NDAA, a $740 billion bill setting policy for the Pentagon that Congress passes
every year.
PAY TO STAY: A controversial idea being floated in
Washington would allocate as much as $25 billion to companies that make
essential goods to move production home, ensuring that even products far down
the supply chain were sourced domestically, according to two administration
officials. No lawmaker has publicly embraced it, but several congressional
aides acknowledged it is part of the broader discussion in Congress. One of the
administration officials said states could administer the funds through their
separate economic development organizations. That would be a boon for states
that are struggling to pay their own bills after widespread lockdowns,
plummeting tax revenues, and a huge surge in COVID-related costs, one state
official said. But given longstanding concerns about the government setting
"industrial policy", the notion of subsidizing industry directly is
polarizing, even among Trump's top advisers. Outright subsidies are a
non-starter, said one of the two administrative sources. "Internally some
are questioning why we should be providing funds to companies that have left in
recent years." White House economic adviser Larry Kudlow has talked
publicly about using tax incentives instead to prod U.S. companies to move some
manufacturing home. White House trade adviser Peter Navarro wants the federal
government to buy more U.S.-made medical goods and drugs, but Trump has not
signed an executive order Navarro is promoting. Treasury Secretary Steven
Mnuchin and others favor building trusted networks of drug and medical
suppliers, said two officials familiar with the discussions. Giving federal
dollars directly to companies to shift supply chains away from China would
likely run afoul of World Trade Organization rules, and could discourage
foreign companies from doing business in the United States, critics of the idea
say. The State Department, meanwhile, is working with other agencies and
foreign governments to diversify American supply chains from China. "This
includes returning manufacturing to the United States and expanding our base of
international manufacturing partners," said a spokesperson.
^ This current pandemic, the secrecy
of the Chinese Communist Government to silence their own people from the start,
the poor quality of PPEs and other medical supplies across the world shows that
we should take a look at our current relationship with China. While I don’t
believe the US should cut diplomatic ties with China I do believe we should not
rely so heavily on them now or in the future. ^
https://finance.yahoo.com/news/u-mulls-paying-companies-tax-050230070.html
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.